Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIMM17B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NDRG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00662 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC01410 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ILVBL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STOML1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANGRF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASAL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NCOR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HGH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAPPC10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAPGEF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRP7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HEMK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIPF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on